StockData
Genprex, Inc. logo

Genprex, Inc. (GNPX) stock

GNPXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.67−0.23 (-12.08%)

Close on Nov 17, 2026Market cap $1.37MP/E –Yield –

Genprex pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

No pe ratio figures for Genprex

Genprex has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Genprex figures

See a number that looks wrong?